Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Glargine and Oral Antidiabetic Drugs (OADs) in Newly Diagnosed Type 2 Diabetes
This study has been completed.
Study NCT00978263   Information provided by Chongqing Medical University

First Received on September 14, 2009.   Last Updated on February 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Glargine
Additional drug interventions recognized in this trial
Hypoglycemic Agents
Metformin
More general drug interventions related to this trial
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Chongqing Medical University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services